Abstract:Influenza represents one of the biggest health threats facing humanity. Seasonal epidemics can transition to global pandemics, with cross-species infection presenting a continuous challenge. Although vaccines and several anti-viral options are available, constant genetic drifts and shifts vitiate any of the aforementioned prevention and treatment options. Therefore, we describe an approach targeted at the virus's channel to derive new anti-viral options. Specifically, Influenza A's M2 protein is a well-characterized channel targeted for a long time by aminoadamantane blockers. However, widespread mutations in the protein render the drugs ineffective. Consequently, we started by screening a repurposed drug library against aminoadamantane-sensitive and resistant M2 channels using bacteria-based genetic assays. Subsequent in cellulo testing and structure-activity relationship studies yielded a combination of Theobromine and Arainosine, which exhibits stark anti-viral activity by inhibiting the virus's channel. The drug duo was potent against H1N1 pandemic swine flu, H5N1 pandemic avian flu, aminoadamantane-resistant and sensitive strains alike, exhibiting activity that surpassed Oseltamivir, the leading anti-flu drug on the market. When this drug duo was tested in an animal model, it once more outperformed Oseltamivir, considerably reducing disease symptoms and viral RNA progeny. In conclusion, the outcome of this study represents a new potential treatment option for influenza alongside an approach that is sufficiently general and readily applicable to other viral targets.

Potent Inhibitor Design Against H1N1 Swine Influenza: Structure-Based and Molecular Dynamics Analysis for M2 Inhibitors from Traditional Chinese Medicine Database.

Molecular Dynamics Analysis of Potent Inhibitors of M2 Proton Channel Against H1N1 Swine Influenza Virus

Screening from the World'S Largest Tcm Database Against H1n1 Virus

Novel Hemagglutinin Inhibitors for H1N1 Influenza Virus Screening from TCM Database

Residue-based Design of Small Molecule Inhibitor for H1N1, H5N1 and H7N1 Mutants

Two Birds with One Stone ? Possible Dual-Targeting H 1 N 1 Inhibitors from Traditional Chinese Medicine

Insights from Investigating the Interactions of Adamantane-Based Drugs with the M2 Proton Channel from the H1N1 Swine Virus

Design and synthesis of pinane oxime derivatives as novel anti-influenza agents

Study on the Mechanisms of Active Compounds in Traditional Chinese Medicine for the Treatment of Influenza Virus by Virtual Screening

Ligand-based Dual Target Drug Design for H1N1: Swine Flu--a Preliminary First Study.

Design And Synthesis Of Heteroaromatic-Based Benzenesulfonamide Derivatives As Potent Inhibitors Of H5n1 Influenza A Virus

Screening the potential H1N1 virus neuraminidase inhibitors from Chinese herbal medicine based on molecular docking

Drug design for Influenza A virus subtype H1N1

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase

Synthesis and Structure-Activity Relationship Study of Arylsulfonamides As Novel Potent H5N1 Inhibitors.

Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus

Identification of a Small-Molecule Inhibitor of Influenza Virus Via Disrupting the Subunits Interaction of the Viral Polymerase.

Rational Design and Optimization of Acylthioureas As Novel Potent Influenza Virus Non-Nucleoside Polymerase Inhibitors.

Antiviral Activities of Several Oral Traditional Chinese Medicines against Influenza Viruses

Potent Anti-Influenza Synergistic Activity of Theobromine and Arainosine